DaShenLin Pharmaceutical Group Co (SHSE:603233) Margin of Safety % (DCF FCF Based): 85.97% (As of Jun. 29, 2026)


SHSE:603233 DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
95 GF Score
Price ¥15.48
GF Value ¥18.69
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DaShenLin Pharmaceutical Group Co Margin of Safety % (DCF FCF Based)?

DaShenLin Pharmaceutical Group Co SHSE:603233 95 Margin of Safety % (DCF FCF Based) is 85.97% as of Jun. 29, 2026. GuruFocus rates SHSE:603233 with a GF Score™ of 95/100 and a GF Value™ of ¥18.69 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-29), DaShenLin Pharmaceutical Group Co's Predictability Rank is 5-Stars. DaShenLin Pharmaceutical Group Co's intrinsic value calculated from the Discounted FCF model is ¥18.26 and current share price is ¥15.48. Consequently,

DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) using Discounted FCF model is 85.97%.

DaShenLin Pharmaceutical Group Co Margin of Safety % (DCF FCF Based) Competitor Comparison

For the Pharmaceutical Retailers subindustry, DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaShenLin Pharmaceutical Group Co Margin of Safety % (DCF FCF Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) falls into.


SHSE:603233
95GF Score
DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaShenLin Pharmaceutical Group Co Margin of Safety % (DCF FCF Based) Calculation

DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(110.34-15.48)/110.34
=85.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

What does a Margin of Safety % (DCF FCF Based) of 85.97% mean?
DaShenLin Pharmaceutical Group Co (SHSE:603233) has a Margin of Safety % (DCF FCF Based) of 85.97% as of Jun. 29, 2026. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on DaShenLin Pharmaceutical Group Co.
Is DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) too high?
DaShenLin Pharmaceutical Group Co's current Margin of Safety % (DCF FCF Based) is 85.97%. Overall, DaShenLin Pharmaceutical Group Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) compare to competitors?
DaShenLin Pharmaceutical Group Co's Margin of Safety % (DCF FCF Based) of 85.97% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF FCF Based) for a Healthcare Providers & Services company?
A good Margin of Safety % (DCF FCF Based) depends on the Healthcare Providers & Services industry context. However, Margin of Safety % (DCF FCF Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF FCF Based) mean?
A high Margin of Safety % (DCF FCF Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF FCF Based) is the percent difference between the current price and the intrinsic DCF FCF price. View historical data on DaShenLin Pharmaceutical Group Co. DaShenLin Pharmaceutical Group Co's current Margin of Safety % (DCF FCF Based) is 85.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaShenLin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co (SHSE:603233) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥18.69, compared to a current price of ¥15.48 — trading 17.2% below its estimated fair value. The current Margin of Safety % (DCF FCF Based) is 85.97%. DaShenLin Pharmaceutical Group Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF FCF Based) calculated?
Margin of Safety % (DCF FCF Based) is calculated from a company's financial statements. For DaShenLin Pharmaceutical Group Co (SHSE:603233), the current Margin of Safety % (DCF FCF Based) is 85.97% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?

Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥15.48 is trading 17.2% below its estimated GF Value™ of ¥18.69. GuruFocus considers DaShenLin Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:603233:

  • Margin of Safety % (DCF FCF Based): 85.97%
  • GF Value™: ¥18.69 vs. price of ¥15.48 (17.2% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaShenLin Pharmaceutical Group Co Business Description

Address No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
95GF Score

Get the complete analysis for SHSE:603233

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.48
Price
¥18.69
GF Value